MentionFox
Home › Stakes › Core Scientific, Inc.
5%+ stakes · Schedule 13D and 13G

Core Scientific, Inc.: 5%+ holders

Who has reported owning 5% or more of Core Scientific, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more7
Filings40
Latest filing2026-08-14
Stated intents1

Core Scientific, Inc. has 40 Schedule 13D or 13G filings on record since 2025-07-16. 7 holders' latest filing reports 5% or more of common stock, par value $0.00001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Stated intent

Intent stated in Item 4 Two Seas Capital LP

The Reporting Persons intend to solicit proxies against the Issuer's proposal to adopt the Merger Agreement at the Special Meeting and also intend to file a proxy statement in connection with the Special Meeting, if and when it is scheduled.From Item 4 of the SCHEDULE 13D filed 2025-08-08

Holders

HolderPercentSharesLatestEvent date
BlackRock, Inc.7.8%23,299,564SCHEDULE 13G/A, 2025-07-162025-06-30
Jericho Capital Asset Management L.P.7.2%22,882,942SCHEDULE 13G, 2026-08-142026-06-30
Kenneth Griffin6.5%20,850,479SCHEDULE 13G, 2026-08-052026-07-29
Jane Street Group, LLC6.3%20,125,585SCHEDULE 13G/A, 2026-08-122026-06-30
Vanguard Portfolio Management5.97%18,843,184SCHEDULE 13G, 2026-04-292026-03-31
Valiant Capital Management, L.P.5.3%16,956,009SCHEDULE 13G/A, 2026-08-142026-06-30
Vanguard Capital Management5.09%16,196,304SCHEDULE 13G, 2026-07-312026-06-30
G1 Execution Services, LLC4.6%14,631,891SCHEDULE 13G/A, 2026-05-152025-03-31
Two Seas Capital LP4.4%13,984,778SCHEDULE 13D/A, 2026-04-232026-04-23
Situational Awareness LP4.4%14,089,395SCHEDULE 13D/A, 2026-08-042026-07-15
Barclays PLC0.42%1,302,387SCHEDULE 13G/A, 2026-02-112025-12-31
Pentwater Capital Management LP0.4%1,336,594SCHEDULE 13G/A, 2026-08-142026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13

Timeline

FiledHolderPercentFiling
2025-07-16BlackRock, Inc.7.8%SCHEDULE 13G/A
2025-07-29The Vanguard Group9.14%SCHEDULE 13G/A
2025-08-08Two Seas Capital LP intent stated6.3%SCHEDULE 13D
2025-08-14G1 Execution Services, LLC6.2%SCHEDULE 13G
2025-08-19Situational Awareness LP5.8%SCHEDULE 13D
2025-10-09Two Seas Capital LP6.5%SCHEDULE 13D/A
2025-10-14Situational Awareness LP9.4%SCHEDULE 13D/A
2025-10-31Two Seas Capital LP5.9%SCHEDULE 13D/A
2025-11-03Valiant Capital Management, L.P.5.8%SCHEDULE 13G
2025-11-12Barclays PLC5.27%SCHEDULE 13G
2025-11-13G1 Execution Services, LLC4.9%SCHEDULE 13G/A
2025-11-14Pentwater Capital Management LP8.5%SCHEDULE 13G
2025-11-17Two Seas Capital LP8%SCHEDULE 13D/A
2025-12-01Two Seas Capital LP7.9%SCHEDULE 13D/A
2025-12-10Citadel Securities GP LLC5.5%SCHEDULE 13G
2025-12-18Two Seas Capital LP8.1%SCHEDULE 13D/A
2026-01-07The Vanguard Group10.95%SCHEDULE 13G/A
2026-01-20Two Seas Capital LP7.2%SCHEDULE 13D/A
2026-02-09Valiant Capital Management, L.P.4.2%SCHEDULE 13G/A
2026-02-11Barclays PLC0.42%SCHEDULE 13G/A
2026-02-13G1 Execution Services, LLC5.6%SCHEDULE 13G
2026-02-19Two Seas Capital LP6.7%SCHEDULE 13D/A
2026-03-04Two Seas Capital LP5.9%SCHEDULE 13D/A
2026-03-12Valiant Capital Management, L.P.5.1%SCHEDULE 13G
2026-03-20Two Seas Capital LP5.5%SCHEDULE 13D/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-16Two Seas Capital LP5.7%SCHEDULE 13D/A
2026-04-23Two Seas Capital LP4.4%SCHEDULE 13D/A
2026-04-29Vanguard Portfolio Management5.97%SCHEDULE 13G
2026-05-15Valiant Capital Management, L.P.5.1%SCHEDULE 13G/A
2026-05-15Citadel Securities GP LLC4.1%SCHEDULE 13G/A
2026-05-15G1 Execution Services, LLC4.6%SCHEDULE 13G/A
2026-05-26Jane Street Group, LLC7.5%SCHEDULE 13G
2026-07-31Vanguard Capital Management5.09%SCHEDULE 13G
2026-08-04Situational Awareness LP4.4%SCHEDULE 13D/A
2026-08-05Kenneth Griffin6.5%SCHEDULE 13G
2026-08-12Jane Street Group, LLC6.3%SCHEDULE 13G/A
2026-08-14Pentwater Capital Management LP0.4%SCHEDULE 13G/A
2026-08-14Valiant Capital Management, L.P.5.3%SCHEDULE 13G/A
2026-08-14Jericho Capital Asset Management L.P.7.2%SCHEDULE 13G

Tools for this story

Each opens in a new tab, filled in for Core Scientific, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/core-scientific-1839341
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Core Scientific, Inc. 5%+ holders: 7 at 5% or more, largest BlackRock, Inc. 7.8%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/core-scientific-1839341